Awareness of the high rate of false positive [68Ga]Ga-prostate specific membrane antigen-11 uptake in the prostate gland: can PET/MRI solve this problem?
False positive 68 Ga-PSMA uptake is common and can affect clinical decisions, including focal therapy or recurrence assessment after radiotherapy. mpMRI helps clarify benign mimics, improving diagnostic accuracy. PET/MRI may offer more reliable assessment of PCa, potentially aiding focal therapy planning and posttreatment evaluation.
Authors
- Çetin Demirdağ (ORCID: https://orcid.org/0000-0002-8912-9155)
- Barış Bakır (ORCID: https://orcid.org/0000-0002-6587-9787)
- Hüseyin Pehlivanoğlu (ORCID: https://orcid.org/0000-0003-4833-0976)
- Haluk Sayman (ORCID: https://orcid.org/0000-0002-0954-5707)
- Lebriz Uslu (ORCID: https://orcid.org/0000-0003-1868-3957)
- Nil Urganci
- Emre Karayel (ORCID: https://orcid.org/0000-0001-8114-2315)
- İclal Gürses (ORCID: https://orcid.org/0000-0003-3301-5420)
- Sevda Özel-Yıldız (ORCID: https://orcid.org/0000-0003-1357-6933)
Institutions
- GTx (United States) (US)
- Istanbul University-Cerrahpaşa (TR)
- Istanbul University (TR)
Publication Details
- Journal
- Nuclear Medicine Communications
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1097/mnm.0000000000002071
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00